Being a medical pathology expert in the COVID-19 pandemic

The aim of the study is to reveal the risk of COVID-19 among pathologists and to examine their views, concerns along with measures to be taken in dealing with COVID-19. The research was carried out in Turkey with online survey method, on 176 participants. According to the findings of the study, participants who served oneon- one to a COVID-19 patient was 47.16%. Number of participants assigned in the polyclinic and clinical processes of coronavirus patients; 63.6%. 24 participant (13.6%) stated that their frozen cases decreased. Substantially, there was a use of protective equipment (88.6%). Cytological specimens were seen to continue 93.7%. There was a competence of 88.6% in terms of protective equipment. It was determined that the anxiety levels of the participants did not change according to age groups, according to the hospital type, working pandemic outpatient clinic and gender variables (p> 0.05). As a result, medical pathologists actively continue their routine services during the pandemic process and also support their other colleagues by working actively in the COVID-19 outpatient clinic. As always, solidarity with our colleagues continues.

PDF

___

1. Figen Sezen. Influenza Pandemileri. Türk Hij Den Biyol Derg. 2009;66:21- 4.

2. Huang C, Wang Y, Li X, , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.

3. T.C. Saglik Bakanligi. Turkiye’deki guncel durum. 2020. Available at: https://covid19.saglik.gov.tr/ accessed date 29 April 2020

4. Lai J, Ma S, Wang Y, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3:203976.

5. Bai Y, Lin CC, Lin CY, et al. Survey of stress reactions among health care workers involved with the SARS outbreak. Psychiatr Serv. 2004;55:1055-7.

6. Republic of Turkey Ministry of Health. Public health general directorate. Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19). Ankara, Turkey: Republic of Turkey Ministry of Health; 2020.

7. World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance, 25 January 2020. World Health Organization; 2020, pp 1-5.

8. Paules CI, Marston HD, Fauci AS. Coronavirus infections—more than just the common cold. JAMA. 2020;323:707–8.

9. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893-7.

10. Buckley C, Wee SL, Qin A. China’s doctors, Fighting the Coronavirus, Beg for masks. https:// www.nytimes.com/2020/02/14/world/asia/ chinacoronavirus-doctors.html. accessed date 29 April 2020

11. Stefan E. Pambuccian.The COVID-19 pandemic: implications for the cytology laboratory. J Am Soc Cytopathol. 2020;9:202-11.

12. Henwood AF. Coronavirus disinfection in histopathology. J Histotechnol. 2020;43:102-4.

13. Darnell ME, Subbarao K, Feinstone SM, et al. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods. 2004;121:85–91.

14. Duan SM, Zhao XS, Wen RF, et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci. 2003;16:246–55.

15. Kampf G, Todt D, Pfaender S, et al. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. 2020;104:246-51.

16. Asmundson GJ, Taylor S, Carleton RN, et al. Should health anxiety be carved at the joint? A look at the health anxiety construct using factor mixture modeling in a non-clinical sample. J Anxiety Disord. 2012;26:246- 51.